Understanding the mechanisms by which cells coordinate their size with their ability to divide has long attracted the interest of biologists. The Target of Rapamycin (TOR) pathway is becoming increasingly recognized as a master regulator of cell size, however less is known how TOR activity might be coupled with the cell cycle. Here, we establish that mTOR complex 1 (mTORC1) promotes cytokinesis through activation of a Rho GTPase-Rho Kinase (ROCK) signaling cascade.
Wee1 mutant cells were shown to abrogate a previously unknown to exist cell size checkpoint strikingly, undergoing cell division at half the size of wild-type cells (1) . Since this discovery, our understanding of the mechanisms controlling cell size and cell division have rapidly, though separately, evolved. The Rho pathway has emerged as a central player in controlling the actin-myosin-based contractile events required for cytokinesis (2, 3) .
Regarding the regulation of cell size, the TOR signaling pathway has received considerable attention, in particular for its role in controlling the G1 growth phase of the cell cycle. Though it has largely become known as a controller of protein synthesis and the G1 program, it has also long been clear that TOR has a second, distinct essential function involving the cell-cycle dependent organization of the cytoskeleton (4) . Mutations in TOR2 do not arrest cells in G1 as is the case with rapamycin treated cells, but rather cause arrest at multiple points in the cell cycle (5) accompanied by profound actin cytoskeletal disorganization (4) . That the lethality of a TOR2 mutation could be rescued by overexpression of components of the Rho pathway hinted at the relationship between these pathways during the cell cycle (6) . However, the importance of such a coupling during cell division still remains largely unknown. To address this question, we have investigated the involvement of mTOR signaling in cytokinesis. We find that mTORC1 hyperactivation causes prolonged cytokinesis due to Rho-ROCK hyperactivity and is associated with increased polyploidy, a condition thought to underlie the malignancy of certain cancers.
Results
The mTOR pathway is repressed through the actions of multiple upstream inhibitory proteins including TSC1, TSC2, PRAS40, PTEN, and REDD1 (7). We recently identified a novel negative regulator of the mTOR pathway, DEPTOR, which binds mTOR and inhibits both mTORC1 and mTORC2 signaling pathways (8) . In characterizing DEPTOR function, we noticed that its depletion in cells by RNAi promoted their multinucleation (Fig. 1A) . To quantify this phenomenon, we measured the DNA content of DEPTOR knockdown cells compared with control cells.
The results were clear; DEPTOR knock-down increased the percentage of 8N cells relative to those of control knockdown cells (Fig. 1B) . Because DEPTOR depletion activates both the mTORC1 and mTORC2 pathways, we sought to determine whether either of these pathways might be responsible for mediating the effects of DEPTOR on ploidy. First, we knocked down known regulators of mTORC1 and/or mTORC2: raptor, rictor, mTOR, TSC1, TSC2, and PTEN and measured their DNA content.
Similar to that of DEPTOR knockdown cells, cells with knockdown of any of the negative regulators of mTOR: TSC1, TSC2, or PTEN increased the percentage of 8N cells relative to control knockdown cells (Fig. 1B) . Fittingly, the increased >4N DNA content of TSC1 knockdown was similar to those seen in a different cell type with complete loss of TSC1 (9) . That neither mTORC1 nor mTORC2 inactivation by knockdown or raptor or rictor, respectively increased the percentage of 8N cells is consistent with DEPTOR being a negative regulator of mTOR signaling (Fig. 1B) . Finally, treatment of DEPTOR or TSC2 knockdown cells with rapamycin, which only significantly inhibits mTORC1 and not mTORC2 in the cells we assessed (8) , fully reduced the percentage of 8N cells (Fig. 1B) suggesting that deregulation of mTORC1 is responsible for effects of mTOR on polyploidy.
To explore at which point in their cell cycle mTORC1-hyperactivated cells became polyploid, we visually monitored individual knockdown cells over time.
Both wild-type and DEPTOR knockdown cells progressed through interphase and through early stages of mitosis similarly ( Fig. 2A) . However, upon daughter cell separation, the surface of DEPTOR knockdown cells, unlike control cells, began to bleb massively and this was subsequently followed after a prolonged period of blebbing by fusion of their membranes and the creation of one cell containing both daughter nuclei ( are core components of the cytoskeleton driving this process (11), therefore we assessed their morphology with or without mTORC1 hyperactivation during multiple stages of cell cycle. Control and DEPTOR knockdown cells had similar cortical actin positioning and assembly of their α-tubulin-containing spindles in mitosis (Fig. 2E ). However, in cytokinesis, while control daughter cells had symmetrical actin cortices, in DEPTOR depleted cells, their actin architecture was grossly disorganized and appeared to be forming blebbing patterns similar to that which we observed in DEPTOR depleted cells by light microscopy ( Fig.2A-B, 2E ).
Actin-myosin contractility provides critical mechanical force to promote cell cleavage in cytokinesis and is known to be coordinated by many Rho-GTPdependent kinases which regulate this contractility by phosphorylating myosin light chain 2 (MLC2) (12) . To test a role for mTORC1 in regulating actin-myosin contractility, we first confirmed in our cell system that the MLC2 phosphorylating kinase, Rho kinase 2 (ROCK2), regulates the morphology of the actin cytoskeleton (13) . While overexpression of kinase dead ROCK2 did not strongly perturb the actin cytoskeleton compared with overexpression of a control protein, overexpression of wild-type ROCK2 produced strong actin blebbing much like that we had seen with DEPTOR knockdown cells (Fig.   2E ). As expected, ROCK2 overexpression also increased S19 MLC2 phosphorylation (Fig. 3A) . To test whether DEPTOR regulated ROCK signaling during cytokinesis, we measured MLC2 phosphorylation in DEPTOR and control knockdown cells. Typical of metazoan cells in cytokinesis, we detected prominent S19 MLC2 phosphorylation in control cells that was reduced by inhibition of ROCK activity ( Fig. 3B) (14, 15) . On the other hand, DEPTOR depleted cells, had substantially elevated levels of S19 MLC2 phosphorylation compared with control cells (Fig.   3C ). That the effects of DEPTOR loss of S19 MLC2 phosphorylation were strongly reduced by ROCK inhibition (Fig. 3B) suggests that DEPTOR loss activates ROCK signaling.
Because it is possible that DEPTOR knockdown activates ROCK signaling independent of its effects on mTORC1, we tested whether mTORC1 inhibition would reverse the effects of DEPTOR depletion on MLC2 phosphorylation. Indeed, treating DEPTOR knockdown cells with either rapamycin or a concentration of Torin1 which only potently inhibits mTORC1 signaling (8) reduced S19 MLC2 phosphorylation (Fig. 3C) . We next sought to determine whether the effects of DEPTOR on ROCK activity were direct. Because ROCK is activated by binding to the active, GTP-bound form of Rho (16) and because TOR is known to regulate Rho GEF activity (6), we tested whether DEPTOR knockdown regulates ROCK by altering the Rho-GTP/GDP state. DEPTOR knockdown cells had higher levels of Rho-GTP than control cells and this increased activity was reduced by rapamycin (Fig. 3D) .
These results are consistent with mTORC1 activating ROCK upstream of ROCK itself by promoting Rho activity.
Because ROCK directly phosphorylates many substrates besides MLC2, we checked whether other ROCK outputs were also regulated by manipulation of mTORC1. Mypt1 is the targeting subunit for the S19 MLC2 phosphatase and is known to be inhibited in its activity by phosphorylation at its T696 site by ROCK (17, 18) . DEPTOR knockdown increased and mTOR knockdown decreased Mypt1 T696 phosphorylation consistent with mTORC1 positively regulating ROCK activity toward this substrate (Fig. 3E) .
Another target of ROCK pathway is Cofilin. Cofilin is an Factin severing protein which is inhibited through its S3 phosphorylation by the ROCK-activated kinase, LIMK1 (19) . Consistent with the effects of DEPTOR knockdown on MLC2 and Mypt1 phosphorylation, S3 cofilin phosphorylation was increased by DEPTOR knockdown above the levels seen in control knockdown in multiple cell types (Fig. 3F) . In total, these results suggest that Rho-ROCK signaling toward multiple effector pathways is positively regulated by mTORC1.
To better define how DEPTOR-mTORC1 controls
Rho-ROCK activity, we assessed DEPTOR localization in cells undergoing cytokinesis. We detected DEPTOR throughout the cell, though it was clearly enriched at the centrosomes and the cleavage furrow, two subcellular localizations, which interestingly are also enriched for ROCK and RhoA, respectively (Fig. 4A) (20, 21) .
Previously, we have shown that DEPTOR phosphorylation state and levels are regulated by growth factors in an mTOR-dependent manner (8), therefore we assessed whether DEPTOR was also regulated in a cell cycledependent manner. Arresting cells in mitosis with nocodazole, a microtubule disrupting agent (22), significantly impaired the gel mobility of the DEPTOR protein, and this gel mobility was restored when nocodazole was removed from the media (Fig. 4B ). This suggests that DEPTOR might be regulated by phosphorylation during completion of the cell cycle.
Because DEPTOR phosphorylation is known to regulate its ability to repress mTOR signaling (8) , we wanted to determine we might be able to overcome this reduction in DEPTOR function during cytokinesis by inducing its overexpression. To do this, we measured histone phosphorylation, which regulates and provides a (Fig. 4C-D) . In summary, this data suggests that DEPTOR is regulated both post-translational and by localization during the later stages of the cell cycle and that inactivation or hyperactivation of mTORC1 signaling both prolong the time necessary to complete cytokinesis.
Discussion
Here we find that increased mTORC1 causes polyploidy due to defective cytokinesis that is correlated with increased Rho-ROCK-mediated phosphorylation of multiple effectors including MLC2, Mypt1, and Cofilin.
While there is some evidence that mTOR regulates Rhodependent processes in mammalian cells (24, 25) , our work, to our knowledge, is the first to demonstrate that mTORC1 regulates cytokinesis via activation of Rho-ROCK signaling. One question still remaining is whether mTORC1 and not mTORC2 controls all mTOR-dependent, Rho signaling processes. Recently, it has been argued that, on the contrary, many of the effects of mTOR on the actin cytoskeleton are due to regulation of TORC2 and not TORC1 signaling (24) . While our work does not directly address these claims, there is precedence with other TORdependent outputs that TORC1 and TORC2 might overlap in function more than is readily appreciated. In yeast, Sch9 is a target of TORC1 and controls longevity in a manner analogous to one of its homologs in higher organisms, Akt, which is an mTORC2, and not mTORC1, substrate (26) (27) (28) . Also, loss-of-function alleles of LST8, a component of both TORC1 and TORC2, regulates rapamycin-sensitive, GAP1 permease sorting in yeast, but in mammals, does not only significant impair mTORC1 function and rather is essential for mTORC2-Akt activity (29, 30) .
Future studies will undoubtedly be needed to better understand the mechanisms by which TOR regulates Rho function. Recently, it has been shown that rapamycin downregulates the translation of ROCK1 (31) .
Whereas, our data suggests that mTORC1 also regulates the Rho pathway upstream of ROCK (Fig. 3E) . Because TOR is known to regulate numerous effectors by their phosphorylation (32), one interesting possibility stemming from our work is to test whether mTORC1 regulates the phosphorylation state of a Rho-GAP or Rho-GEF. By answering this as well as other questions of how TOR and Rho work, it is exciting to consider that understanding of one of biology's central questions 'how cell size is coordinated with cell division' will be closer in reach. 
Live Cell Imaging
HeLa cells were plated on glass-bottom dishes (MatTek).
Cells were imaged with an ORCA-ER camera (Hammamatsu) attached to a Nikon TE2000 microscope.
All images were collected, measured, and compiled with the aid of Metamorph imaging software (Molecular Devices) and Adobe Photoshop. For time-lapse imaging, cells were kept at 37°C with the aid of a Solent incubation chamber (Solent Inc.).
Fluorescence Activated Cell Sorting
Exponentially growing cells were treated as indicated, trypsinized, washed once in ice-cold PBS and fixed overnight in 1 ml 70% ethanol on ice. Cells were washed once in PBS and incubated in PBS containing 70 µM propidium iodide and 10 mg/ml RNAse A at 37°C for 30 minutes. Flow cytometry analysis was performed using a Becton-Dickinson FACScan machine and CellQUEST DNA Acquisition software.
